NCT06938451Not yet recruiting
Relationship Between FGF19 Overexpression and Disease Prognosis
A Real-world Study of FGF19 Overexpression Status and Treatment Outcome and Prognosis in Advanced Hepatocellular Carcinoma
Source: ClinicalTrials.gov · Last updated 22 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
A real-world study of FGF19 overexpression status and treatment outcome and prognosis in advanced hepatocellular carcinoma
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 27 Mar 2025
- Start date
- 1 May 2025
- Primary completion date
- 31 Dec 2028
- Lead sponsor
- Beijing Tsinghua Chang Gung Hospital
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT06938451
What you commit to
- Study type: Observational
- Planned participants: 100
- From 1 May 2025 to the primary completion date, 31 Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Other conditions that, in the opinion of the investigator, make participation in this trial inappropriate
Other
- Fibrous laminae or sarcomatoid HCC or mixed HCC-ICC, or other rare non-HCC pathologic subtypes
Who the study is looking for
- Age ≥18 years on the day of signing the informed consent form
- Histologically or clinically confirmed diagnosis of intermediate to advanced HCC
- Adequate tissue samples of previous liver cancer
- Expected survival of more than 3 months
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Beijing Tsinghua Changgung Hospital Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.